Tekla Capital Management LLC Adamas Pharmaceuticals, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M